News
Portfolio Company News
- February 19, 2013
Data Demonstrating the Safety and Efficacy of Chimerix’s Antiviral CMX001 Presented at BMT Tandem Meetings
- February 13, 2013
Ablynx's Anti-IL-6R Nanobody, ALX-0061, Shows Excellent 24 Week Safety and Efficacy Results in a Phase II Clinical Trial in Rheumatoid Arthritis
- February 10, 2013
Nanōmix Initiates Clinical Testing of Point of Care IVD Cardiac Panel
- February 07, 2013
Innate Pharma Reports Increase in Annual Revenue for 2012
- February 06, 2013
Medical Device Daily: Med-Tech Notes - Carbylan BioSurgery, Inc. - February 05, 2013
Portola Enters into Clinical Collaboration Agreement with Bayer and Janssen for Phase 2 Study of Universal Factor Xa Inhibitor Antidote, PRT4445, and XARELTO®
- January 29, 2013
Portola and Lee’s Pharmaceutical Enter into Agreement to Expand Phase 3 APEX Study of Betrixaban into China
- January 23, 2013
Trevena, Inc. - JPET publication describes the discovery and activity of TRV130
- January 21, 2013
Kiadis Pharma Granted U.S. Patent for its Blood Cancer Treatment ATIR™
- January 16, 2013
Astex Pharmaceuticals, Inc. - Cancer Research UK and Cancer Research Technology Initiate AT13148 Clinical Trial to
Treat Several Cancer Types
- January 08, 2013
First Subject Enrolled in OPUS-2, SARcode Bioscience’s Second Pivotal Study of Lifitegrast Ophthalmic Solution
- January 08, 2013
Vertiflex®, Inc. Announces FDA Clearance of Two Key Additions to Technology Portfolio
- January 07, 2013
ChemoCentryx Advances a New Generation CCR9 Inhibitor, CCX507, Into Clinical Development
- January 07, 2013
MacroGenics and Gilead Sciences Enter Strategic Alliance to Develop and Commercialize Four DART™ Products
- January 07, 2013
Esperion Announces Positive Topline Results from a Phase II Clinical Trial of ETC-1002 in Patients with Type 2 Diabetes
- January 03, 2013
Sutro Biopharma to Collaborate with Sanofi Pasteur on a Novel Production Approach for Vaccine Candidates
- January 03, 2013
Veloxis’ Phase 3 Trial of LCP-Tacro™ in Stable Kidney Transplant Patients, the 3001 Study, Published Online in the American Journal of Transplantation
- January 02, 2013
Astex Pharmaceuticals Announces Initiation of SGI-110 Phase 2 Trial in Advanced Hepatocellular Carcinoma (HCC) Patients
- December 18, 2012
Sutro Biopharma Collaborates with Celgene Corporation to Design and Develop Next-Generation Antibody Drug Conjugates and
Bispecific Antibodies
- December 17, 2012
Medical Device Daily: Insulet Takes Insulin Delivery to Another Level with OmniPod
< Previous | Next >
